alpha-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Term ID

CHEBI:71282

Synonyms

2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranose
alpha-D-GlcNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc
GlcNAca1-4Galb1-4GlcNAcb1-3Galb1-4Glcb
GlcNAcalpha1-4Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta
N-acetyl-alpha-D-glucosaminyl-(1->4)-beta-D-galactosyl-(1->4)-N-acetyl-alpha-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucose

Definition

A linear amino pentasaccharide comprising β-D-glucose at the reducing end with an N-acetyl-β-D-glucosaminyl-(1→4)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→4)-β-D-galactosyl moiety at the 4-position.

References

glygen:G20818VS
glytoucan:G20818VS
pubmed:19443021
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype where environments contain alpha-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype modified by environments containing alpha-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Phenotype affecting alpha-D-GlcpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp

Human Disease Model